“달서립카페👞 ｛OPDAL020.COM｝오피달리기 🌦달서건마♓️달서안마😿달서키스방🌰달서휴게텔🏄달서휴게텔🚆달서휴게텔🐀”的搜索结果，显示 271-280 项，共有 16258 项

1. 褪黑素的副作用：有哪些风险？ - 妙佑医疗国际

   短期抑郁情绪; 易激惹; 胃痉挛; 腹泻; 便秘; 食欲下降; 夜间尿失禁; 跌倒风险增加; 癫痫发作风险增加; 意识混乱或定向障碍; 情绪波动 ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of this study is to determine the confirmed investigator-assessed objective response rate of XMT-1536 (upifitamab rilsodotin) in ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of this study is to determine the confirmed investigator-assessed objective response rate of XMT-1536 (upifitamab rilsodotin) in ...

5. 医生与科室 - 妙佑医疗国际

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objectives for this study are: The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

8. 泌尿科- 临床试验- 妙佑医疗国际

   This clinical trial is designed to assess the safety, dosing, and preliminary efficacy of a novel penile traction device on correcting deformities relating ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...